A single oral saturated fat load could rapidly increase hepatic lipid storage and insulin resistance, accompanied by regulation of hepatic gene expression and signaling that may contribute to the development of MASLD, the most prevalent CLD29. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.